Laura Clague

Companies

• Standard BioTools Inc.Board member Nov 1, 2018 to Jun 16, 2023¹
• Travere Therapeutics, Inc.Chief financial officer Nov 17, 2014 to May 12, 2022²
• GenasysBoard member Feb 2, 2007 to Apr 27, 2022³
• Turtle Beach CorpBoard member Aug 23, 2010 to Aug 23, 2010⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTravere Therapeutics, Inc. TVTX35,655 shares⁵$1.9M at $53.15May 11, 2022
• GGenasys GNSS286,311 shares⁶$369.3K at $1.29Apr 27, 2022
• SBStandard BioTools Inc. LAB104,791 shares⁷$69.2K at $0.66Jun 14, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 14, 2023Granted 26,376 shares of Standard BioTools Inc.⁷
• Jun 15, 2022Granted 30,914 shares of Standard BioTools Inc.⁸
• May 11, 2022Sold 1,375 shares at $21.51 of Travere Therapeutics, Inc.⁵
• May 10, 2022Sold 825 shares at $21.51 of Travere Therapeutics, Inc.⁵
• Apr 27, 2022Exercised options 50,000 shares at $1.33 of Genasys⁶
• Mar 15, 2022Granted 30,000 shares of Genasys⁹
• Feb 23, 2022Sold 13,716 shares at $3.14 of Genasys¹⁰
• Feb 23, 2022Exercised options 20,000 shares at $2.16 of Genasys¹⁰
• Jan 31, 2022Sold 1,238 shares at $27.40 of Travere Therapeutics, Inc.¹¹
• Jan 31, 2022Granted 9,840 shares of Travere Therapeutics, Inc.¹¹
• Jan 24, 2022Sold 2,063 shares at $24.98 of Travere Therapeutics, Inc.¹²
• Jan 11, 2022Sold 7,500 shares at $27.40 of Travere Therapeutics, Inc.¹³
• Jan 10, 2022Granted 7,500 shares of Travere Therapeutics, Inc.¹³